Cara Therapeutics Statistics

Total Valuation

CARA has a market cap or net worth of $16.00 million. The enterprise value is $6.55 million.

Market Cap	16.00M
Enterprise Value	6.55M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, after market close.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

CARA has 54.85 million shares outstanding. The number of shares has increased by 1.24% in one year.

Shares Outstanding	54.85M
Shares Change (YoY)	+1.24%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	34.01%
Float	46.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.45
Forward PS	3.06
PB Ratio	1.38
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.59, with a Debt / Equity ratio of 4.07.

Current Ratio	4.59
Quick Ratio	4.20
Debt / Equity	4.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.35

Financial Efficiency

Return on equity (ROE) is -184.32% and return on invested capital (ROIC) is -77.80%.

Return on Equity (ROE)	-184.32%
Return on Assets (ROA)	-63.43%
Return on Capital (ROIC)	-77.80%
Revenue Per Employee	$199,927
Profits Per Employee	-$2.02M
Employee Count	55
Asset Turnover	0.11
Inventory Turnover	35.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.39% in the last 52 weeks. The beta is 0.68, so CARA's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-78.39%
50-Day Moving Average	0.29
200-Day Moving Average	0.53
Relative Strength Index (RSI)	55.29
Average Volume (20 Days)	465,867

Short Selling Information

The latest short interest is 609,721, so 1.11% of the outstanding shares have been sold short.

Short Interest	609,721
Short Previous Month	832,171
Short % of Shares Out	1.11%
Short % of Float	1.30%
Short Ratio (days to cover)	1.94

Income Statement

In the last 12 months, CARA had revenue of $11.00 million and -$111.08 million in losses. Loss per share was -$2.04.

Revenue	11.00M
Gross Profit	-77.85M
Operating Income	-104.98M
Pretax Income	-122.54M
Net Income	-111.08M
EBITDA	-104.72M
EBIT	-104.98M
Loss Per Share	-$2.04

Full Income Statement

Balance Sheet

The company has $56.62 million in cash and $47.16 million in debt, giving a net cash position of $9.45 million or $0.17 per share.

Cash & Cash Equivalents	56.62M
Total Debt	47.16M
Net Cash	9.45M
Net Cash Per Share	$0.17
Equity (Book Value)	11.60M
Book Value Per Share	0.21
Working Capital	49.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.91 million and capital expenditures -$3.42 million, giving a free cash flow of -$83.33 million.

Operating Cash Flow	-79.91M
Capital Expenditures	-3.42M
Free Cash Flow	-83.33M
FCF Per Share	-$1.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-954.75%
Pretax Margin	-1,010.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-537.99%

Dividends & Yields

CARA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.24%
Shareholder Yield	-1.24%
Earnings Yield	-694.07%
FCF Yield	-520.65%

Analyst Forecast

The average price target for CARA is $1.00, which is 242.70% higher than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	242.70%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	25.59%
EPS Growth Forecast (5Y)	-21.83%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARA has an Altman Z-Score of -17.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.31
Piotroski F-Score	1